Compare STTK & TACO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | TACO |
|---|---|---|
| Founded | 2016 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.6M | 393.2M |
| IPO Year | 2020 | 2025 |
| Metric | STTK | TACO |
|---|---|---|
| Price | $4.54 | $10.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $15.40 | N/A |
| AVG Volume (30 Days) | ★ 841.6K | 214.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ 0.29 |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.28 | N/A |
| P/E Ratio | ★ N/A | $36.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $10.11 |
| 52 Week High | $8.33 | $10.59 |
| Indicator | STTK | TACO |
|---|---|---|
| Relative Strength Index (RSI) | 36.65 | 67.98 |
| Support Level | $4.38 | $10.44 |
| Resistance Level | $7.66 | $10.55 |
| Average True Range (ATR) | 0.39 | 0.01 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 13.92 | 88.89 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Berto Acquisition Corp is a blank check company.